India-Latin America trade and collaboration prospects discussed at Kerala University conference

A panel discussion on ‘India-Latin America Business Prospects’ was held at the University of Kerala on Friday as part of the Centre for Latin American Studies (CLAS) international conference on the topic ‘Partners in Progress: Enhancing Synergies and Complementarities between India and Latin America’.

The session saw a convergence of scholars, diplomats, and experts in the field of India-Latin America relations, who shared their insights on the growing trade and business prospects between the regions.
Pablo Kunik, an economist from Argentina, opened the discussion by providing an overview of the expanding multilateral trade relations between India and Latin America. He highlighted the success of Indian companies such as Tata Motors and Mahindra in Latin American markets, especially Brazil and Mexico.

Dr. Kunik focused on the bilateral trade between India and Argentina, observing that trade had surged to approximately $3.2 billion in 2023. India exports pharmaceuticals, automobiles, textiles, machinery and IT services to Argentina, while Argentina sends agricultural products, including soybeans and meat to India.

G. Levin, chief executive officer of K-Space, spoke about the potential for India’s collaboration with Latin American countries, especially in space research. Highlighting the advantages of Latin America’s proximity to the equator, Mr. Levin emphasised how the Indian Space Research Organisation could extend its services to Latin America, further strengthening the region’s space capabilities.

Former diplomat R. Viswanathan, a Latin America expert and CLAS executive council member, also shared success stories of Indian companies in Latin America, such as Tata Consultancy Services (TCS) in Uruguay, and stressed the growing economic collaboration. He noted that such partnerships represent a new paradigm of business between India and Latin America, benefiting both regions in numerous sectors, including IT, energy and manufacturing.

Godavarthi Venkata Srinivas, Additional Secretary of the Latin America and Caribbean Division in the Ministry of External Affairs chaired the session.

  • Related Posts

    Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

    Gleneagles BGS Hospital, Kengeri, Bengaluru, part of the Fortis Healthcare Network, marked World Organ Donation Day with its annual commemorative event, ‘A Legacy That Lives On.’ The event brought together…

    NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

    Punjab: The Narcotics Control Bureau (NCB) has uncovered an alleged pharmaceutical-drug diversion network operating through rural areas of Punjab. Investigators are tracing the movement of fentanyl and other drugs regulated…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

    Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

    NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

    NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

    Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

    Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

    Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

    Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

    ‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

    ‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses